Concepedia
Statistics
Publications
9
Citations
413
H-Index
Active since
1993
Affiliations
UNSW Sydney(Current)
Children's Cancer Institute Australia
AR2i
Prince of Wales Hospital
Cancer Institute of New South Wales
S. Decollogne is an author at UNSW Sydney specializing in molecular oncology, medicine, and oncology.
Publications per year
1993–2015
A peptide trivalent arsenical inhibits tumor angiogenesis by perturbing mitochondrial function in angiogenic endothelial cells
Anthony S. Don, O. Kisker, Pierre J. Dilda et al. · Cancer Cell · 2003 · 150 citations · Full text
Medicine, Cancer Biology, Oncology +14
NMDA Receptor Complex Blockade by Oral Administration of Magnesium: Comparison with MK-801
S. Decollogne · Pharmacology Biochemistry and Behavior · 1997 · 83 citations
Medicine, Pharmacology, Pharmacotherapy +9
Dual-targeting of aberrant glucose metabolism in glioblastoma
Han Shen, S. Decollogne, Pierre J. Dilda et al. · Journal of Experimental & Clinical Cancer Research · 2015 · 59 citations · Full text
Life Sciences, Oncology, Pharmacology +17
Optimization of the Antitumor Efficacy of a Synthetic Mitochondrial Toxin by Increasing the Residence Time in the Cytosol
Pierre J. Dilda, S. Decollogne, Lakmini Weerakoon et al. · Journal of Medicinal Chemistry · 2009 · 41 citations
Medicine, Oncology, Pharmacology +14
Alterations in the mitochondrial responses to PENAO as a mechanism of resistance in ovarian cancer cells
S. Decollogne, Swapna Joshi, Sylvia A. Chung et al. · Gynecologic Oncology · 2015 · 20 citations
Life Sciences, Cell Biology, Oncology +14
1–5 of 9